ORIC Oric Pharmaceuticals, Inc. - Common Stock
ORIC Aktien-Snapshot Kurs, Marktkapitalisierung, P/E, EPS, ROE, Schulden/Eigenkapital, 52-Wochen-Spanne
ORIC Aktienkurs-Chart Täglich OHLCV mit technischen Indikatoren — Schwenken, Zoom und Ansicht anpassen
10-Jahres-Performance Umsatz-, Nettoergebnis-, Margen- und EPS-Trends
Bewertung P/E-, P/S-, P/B-, EV/EBITDA-Verhältnisse — ist die Aktie teuer oder günstig?
Rentabilität Brutto-, Betriebs- und Nettomargen; ROE, ROA, ROIC
Finanzielle Gesundheit Verschuldung, Liquidität, Solvenz — Bilanzstärke
Wachstum Umsatz-, EPS- und Nettoergebniswachstum: YoY, 3-Jahres-CAGR, 5-Jahres-CAGR
Kapitaleffizienz Umsatz pro Vermögenswert, Lagerumschlag, Forderungsumschlag
ORIC Analysten-Konsens Bullische und bärische Analystenmeinungen, 12-Monats-Kursziel, Aufwärtspotenzial
- Starker Kauf 9 42,9%
- Kauf 10 47,6%
- Halten 2 9,5%
- Verkauf 0 0,0%
- Starker Verkauf 0 0,0%
12-Monats-Kursziel
12 Analysten · 2026-08-19Ergebnisverlauf EPS Ist vs. Schätzung, Überraschung %, Beat-Rate, nächstes Ergebnisdatum
| Zeitraum | EPS Actual | EPS est. | Überraschung |
|---|---|---|---|
| 30. Juni 2026 | $-0.38 | $-0.37 | -0.01% |
| 31. März 2026 | $-0.34 | $-0.33 | -0.01% |
| 31. Dezember 2025 | $-0.30 | $-0.37 | 0.07% |
| 30. September 2025 | $-0.33 | $-0.41 | 0.08% |
| 30. Juni 2025 | $-0.47 | $-0.45 | -0.02% |
| 31. März 2025 | $-0.42 | $-0.52 | 0.10% |
Peer-Vergleich (GICS-Subbranche) Wichtige Kennzahlen im Vergleich zu Branchenkollegen
| Ticker | Marktkapitalisierung | P/E | Umsatz Vj. | Nettomarge | ROE | Bruttogewinnmarge |
|---|---|---|---|---|---|---|
| ORIC | $806M | -5.6 | — | — | -36.5% | — |
| ABSI | $529M | -4.2 | -38.2% | -4113.7% | -63.5% | — |
| XNCR | $1.10B | -12.3 | 13.7% | -73.2% | -14.0% | — |
| TYRA | $1.41B | -13.1 | — | — | -42.7% | — |
| PURR | — | — | — | — | — | — |
| VIR | $841M | -1.9 | -7.6% | -638.9% | -51.1% | — |
| INBX | $1.15B | -8.7 | 550.0% | -10773.5% | -365.9% | — |
| AVBP | $854M | -4.7 | — | — | -59.7% | — |
| JBIO | $761M | -4.8 | — | — | -47.7% | — |
| REPL | $633M | -2.3 | — | — | -146.2% | — |
| MGTX | $645M | -5.6 | 144.6% | -140.3% | 8062.2% | — |
Vollständige Fundamentaldaten Alle Kennzahlen nach Jahr — Gewinn- und Verlustrechnung, Bilanz, Cashflow
Gewinn- und Verlustrechnung 11
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
| SG&A Expense | $33M | $29M | $26M | $25M | $22M | $13M | $6M | |
| Operating Expenses | $143M | $143M | $111M | $92M | $79M | $74M | $29M | |
| Operating Income | $-143M | $-143M | $-111M | $-92M | $-79M | $-74M | $-29M | |
| Other Non-op | $14M | $15M | $10M | $3M | $156.0K | $483.0K | $2M | |
| Income Tax | $0 | $0 | $0 | $0 | $0 | $0 | $0 | |
| Net Income | $-129M | $-128M | $-101M | $-89M | $-79M | $-74M | $-27M | |
| EPS (Basic) | $-1.47 | $-1.83 | $-1.96 | $-2.25 | $-2.07 | · | · | |
| EPS (Diluted) | $-1.47 | $-1.83 | $-1.96 | $-2.25 | $-2.07 | · | · | |
| Shares (Basic) | 87,793,801 | 69,727,940 | 51,450,848 | 39,655,260 | 37,954,280 | · | · | |
| Shares (Diluted) | 87,793,801 | 69,727,940 | 51,450,848 | 39,655,260 | 37,954,280 | · | · | |
| EBITDA | $-143M | $-143M | $-111M | $-92M | $-79M | $-74M | · |
Bilanz 22
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $46M | $59M | $23M | $67M | $226M | $78M | $89M | |
| Short-term Investments | · | · | · | · | · | $215M | · | |
| Prepaid Expense | $7M | $6M | $4M | $4M | $4M | $3M | $840.0K | |
| Current Assets | $288M | $262M | $213M | $210M | $241M | $297M | $90M | |
| PP&E (Net) | $2M | $3M | $3M | $3M | $2M | $2M | $2M | |
| PP&E (Gross) | $10M | $10M | $9M | $9M | $7M | $6M | $6M | |
| Accum. Depreciation | $8M | $7M | $6M | $6M | $5M | $4M | $4M | |
| Other Non-current Assets | $7M | $9M | $10M | $12M | $12M | $319.0K | $2M | |
| Total Assets | $409M | $274M | $252M | $247M | $299M | $299M | $94M | |
| Accounts Payable | $4M | $2M | $944.0K | $1M | $2M | $757.0K | $152.0K | |
| Accrued Liabilities | $17M | $23M | $20M | $14M | $13M | $8M | $5M | |
| Current Liabilities | $20M | $25M | $20M | $15M | $15M | $9M | $5M | |
| Capital Leases | $4M | $6M | $7M | $9M | $10M | · | · | |
| Other Non-current Liabilities | $4M | $6M | $7M | $9M | $11M | $219.0K | · | |
| Total Liabilities | $25M | $31M | $28M | $25M | $26M | $9M | $6M | |
| Long-term Debt | · | · | · | · | $10M | · | · | |
| Common Stock | $11.0K | $7.0K | $6.0K | $5.0K | $4.0K | $4.0K | · | |
| Retained Earnings | $-692M | $-563M | $-435M | $-334M | $-245M | $-166M | $-93M | |
| AOCI | $786.0K | $379.0K | $258.0K | $-1M | $-103.0K | $-31.0K | · | |
| Stockholders' Equity | $384M | $243M | $224M | $222M | $273M | $290M | $-90M | |
| Liabilities + Equity | $409M | $274M | $252M | $247M | $299M | $299M | $94M | |
| Shares Outstanding | 98,528,949 | 71,021,855 | 54,865,553 | 45,089,537 | 39,430,120 | 36,672,415 | 1,984,222 |
Cashflow 9
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
| Stock-based Comp | $25M | $20M | $15M | $14M | $13M | $5M | $1M | |
| Operating Cash Flow | $-111M | $-113M | $-86M | $-75M | $-60M | $-45M | $-24M | |
| CapEx | $712.0K | $1M | $849.0K | $2M | $939.0K | $667.0K | $768.0K | |
| Investing Cash Flow | $-148M | $22M | $-43M | $-109M | $158M | $-216M | $-768.0K | |
| Stock Issued | $244M | $125M | $85M | $25M | $50M | $271M | · | |
| Net Stock Activity | $244M | $125M | $85M | $25M | $50M | $133M | · | |
| Financing Cash Flow | $245M | $127M | $86M | $25M | $49M | $251M | $71M | |
| Net Change in Cash | $-14M | $36M | $-43M | $-159M | $148M | $-11M | $47M | |
| Free Cash Flow | $-112M | $-114M | $-87M | $-77M | $-60M | $-46M | · |
Rentabilität 2
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
| ROA | -37.9% | -48.6% | -40.3% | -32.7% | -26.3% | -37.5% | · | |
| ROE | -36.5% | -49.5% | -42.7% | -40.8% | -27.9% | -31.1% | · |
Liquidität & Solvenz 2
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
| Current Ratio | 14.1 | 10.6 | 10.4 | 13.7 | 15.9 | 33.0 | · | |
| Quick Ratio | 2.2 | 2.4 | 1.1 | 4.3 | 14.9 | 32.6 | · |
Bewertung (TTM) 8
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
| Net Income TTM | $-129M | $-128M | $-101M | $-89M | $-79M | $-74M | · | |
| Market Cap | $806M | $573M | $505M | $266M | $580M | $1.24B | · | |
| P/E | -5.6 | -4.4 | -4.7 | -2.6 | -7.1 | · | · | |
| P/B | 2.1 | 2.4 | 2.3 | 1.2 | 2.1 | 4.3 | · | |
| P / Tangible Book | 2.1 | 2.4 | 2.3 | 1.2 | 2.1 | 4.3 | · | |
| P / Cash Flow | -7.3 | -5.1 | -5.9 | -3.5 | -9.7 | -27.4 | · | |
| P / FCF | -7.2 | -5.0 | -5.8 | -3.4 | -9.6 | -27.0 | · | |
| Earnings Yield | -18.0% | -22.7% | -21.3% | -38.2% | -14.1% | · | · |
Gewinn- und Verlustrechnung 10
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| SG&A Expense | $9M | $8M | $9M | $8M | $9M | $8M | $8M | $7M | $7M | $7M | $7M | $6M | $6M | $6M | $6M | $6M | |
| Operating Expenses | $45M | $40M | $35M | $37M | $39M | $33M | $40M | $38M | $36M | $29M | $31M | $29M | $25M | $26M | $22M | $26M | |
| Operating Income | $-45M | $-40M | $-35M | $-37M | $-39M | $-33M | $-40M | $-38M | $-36M | $-29M | $-31M | $-29M | $-25M | $-26M | $-22M | $-26M | |
| Other Non-op | $4M | $4M | $4M | $4M | $3M | $3M | $3M | $4M | $4M | $4M | $3M | $3M | $2M | $2M | $1M | $865.0K | |
| Net Income | $-41M | $-36M | $-31M | $-33M | $-36M | $-30M | $-36M | $-35M | $-32M | $-25M | $-28M | $-25M | $-23M | $-24M | $-21M | $-25M | |
| EPS (Basic) | $-0.38 | $-0.34 | $-0.25 | $-0.33 | $-0.47 | $-0.42 | $-0.52 | $-0.49 | $-0.45 | $-0.37 | $-0.49 | $-0.44 | $-0.50 | $-0.53 | $-0.52 | $-0.63 | |
| EPS (Diluted) | $-0.38 | $-0.34 | $-0.25 | $-0.33 | $-0.47 | $-0.42 | $-0.52 | $-0.49 | $-0.45 | $-0.37 | $-0.49 | $-0.44 | $-0.50 | $-0.53 | $-0.52 | $-0.63 | |
| Shares (Basic) | 108,012,388 | 105,472,766 | -160,326,367 | 98,953,331 | 78,126,257 | 71,040,580 | -138,512,709 | 70,542,684 | 70,348,414 | 67,349,551 | -96,695,752 | 57,402,226 | 45,654,208 | 45,090,166 | -78,833,750 | 39,575,660 | |
| Shares (Diluted) | 108,012,388 | 105,472,766 | -160,326,367 | 98,953,331 | 78,126,257 | 71,040,580 | -138,512,709 | 70,542,684 | 70,348,414 | 67,349,551 | -96,695,752 | 57,402,226 | 45,654,208 | 45,090,166 | -78,833,750 | 39,575,660 | |
| EBITDA | $-45M | $-40M | · | $-37M | $-39M | $-33M | · | $-38M | $-36M | $-29M | · | $-29M | $-25M | $-26M | · | $-26M |
Bilanz 20
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $37M | $56M | $46M | $50M | $76M | $49M | $59M | $44M | $50M | $56M | $23M | $26M | $104M | $59M | $67M | $29M | |
| Prepaid Expense | $9M | $8M | $7M | $8M | $9M | $8M | $6M | $7M | $8M | $7M | $4M | $5M | $4M | $4M | $4M | $5M | |
| Current Assets | $274M | $290M | $288M | $296M | $291M | $211M | $262M | $279M | $295M | $324M | $213M | $232M | $268M | $193M | $210M | $199M | |
| PP&E (Net) | $2M | $2M | $2M | $3M | $3M | $3M | $3M | $3M | $3M | $3M | $3M | $3M | $3M | $3M | $3M | $3M | |
| PP&E (Gross) | $10M | $10M | $10M | $11M | $11M | $11M | $10M | $10M | $10M | $9M | $9M | $10M | $10M | $9M | $9M | $9M | |
| Accum. Depreciation | $8M | $8M | $8M | $8M | $8M | $8M | $7M | $7M | $7M | $7M | $6M | $7M | $6M | $6M | $6M | $6M | |
| Other Non-current Assets | $6M | $7M | $7M | $7M | $8M | $8M | $9M | $10M | $9M | $9M | $10M | $10M | $11M | $11M | $12M | $12M | |
| Total Assets | $405M | $437M | $409M | $431M | $347M | $243M | $274M | $302M | $329M | $351M | $252M | $274M | $292M | $227M | $247M | $238M | |
| Accounts Payable | $4M | $3M | $4M | $3M | $3M | $5M | $2M | $4M | $2M | $3M | $944.0K | $4M | $3M | $2M | $1M | $2M | |
| Accrued Liabilities | $17M | $15M | $17M | $17M | $15M | $12M | $23M | $17M | $17M | $12M | $20M | $15M | $11M | $13M | $14M | $12M | |
| Current Liabilities | $21M | $18M | $20M | $20M | $18M | $18M | $25M | $21M | $20M | $15M | $20M | $19M | $15M | $15M | $15M | $13M | |
| Capital Leases | · | · | $4M | · | · | · | $6M | · | · | · | $7M | · | · | · | $9M | · | |
| Other Non-current Liabilities | $3M | $3M | $4M | $4M | $5M | $6M | $6M | $7M | $7M | $7M | $7M | $8M | $8M | $9M | $9M | $10M | |
| Total Liabilities | $23M | $21M | $25M | $24M | $23M | $23M | $31M | $28M | $27M | $22M | $28M | $27M | $23M | $24M | $25M | $23M | |
| Common Stock | $11.0K | $11.0K | $11.0K | $11.0K | $9.0K | $7.0K | $7.0K | $7.0K | $7.0K | $7.0K | $6.0K | $6.0K | $6.0K | $5.0K | $5.0K | $4.0K | |
| Retained Earnings | $-770M | $-728M | $-692M | $-662M | $-629M | $-593M | $-563M | $-526M | $-492M | $-460M | $-435M | $-407M | $-381M | $-358M | $-334M | $-313M | |
| AOCI | $-1M | $-290.0K | $786.0K | $615.0K | $187.0K | $209.0K | $379.0K | $722.0K | $-256.0K | $-162.0K | $258.0K | $-369.0K | $-567.0K | $-499.0K | $-1M | $-2M | |
| Stockholders' Equity | $381M | $416M | $384M | $407M | $324M | $220M | $243M | $274M | $302M | $329M | $224M | $247M | $269M | $203M | $222M | $215M | |
| Liabilities + Equity | $405M | $437M | $409M | $431M | $347M | $243M | $274M | $302M | $329M | $351M | $252M | $274M | $292M | $227M | $247M | $238M | |
| Shares Outstanding | 103,636,424 | 103,486,412 | 98,528,949 | 97,278,032 | 86,187,328 | 71,078,511 | 71,021,855 | 70,559,183 | 67,672,303 | 67,420,338 | 54,865,553 | 54,540,715 | 54,532,171 | 45,091,215 | 45,089,537 | 39,576,047 |
Cashflow 9
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock-based Comp | $7M | $7M | $6M | $6M | $7M | $7M | $5M | $5M | $5M | $5M | $4M | $4M | $4M | $4M | $3M | $3M | |
| Operating Cash Flow | $-32M | $-32M | $-22M | $-25M | $-31M | $-33M | $-28M | $-29M | $-26M | $-30M | $-24M | $-20M | $-21M | $-21M | $-15M | $-19M | |
| CapEx | $356.0K | $2.0K | $227.0K | $35.0K | $63.0K | $387.0K | $219.0K | $418.0K | $333.0K | $218.0K | $57.0K | $77.0K | $405.0K | $310.0K | $287.0K | $401.0K | |
| Investing Cash Flow | $12M | $-18M | $17M | $-111M | $-77M | $22M | $43M | $23M | $18M | $-62M | $21M | $-58M | $-19M | $13M | $28M | $-685.0K | |
| Stock Issued | $0 | $61M | $0 | $110M | $134M | $0 | $0 | $0 | $0 | $125M | $0 | $226.0K | $85M | $0 | $25M | $-354.0K | |
| Net Stock Activity | · | $61M | · | · | · | $0 | · | · | · | $125M | · | · | · | · | · | · | |
| Financing Cash Flow | $828.0K | $61M | $2M | $109M | $134M | $11.0K | $575.0K | $126.0K | $816.0K | $125M | $453.0K | $31.0K | $85M | $0 | $25M | $1.0K | |
| Net Change in Cash | $-19M | $11M | $-4M | $-26M | $27M | $-10M | $15M | $-6M | $-7M | $33M | $-3M | $-77M | $45M | $-8M | $38M | $-20M | |
| Free Cash Flow | · | $-32M | · | · | · | $-33M | · | · | · | $-30M | · | · | · | $-21M | · | · |
Rentabilität 2
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ROA | -11.0% | -10.5% | · | -8.9% | -10.8% | -10.1% | · | -12.0% | -10.3% | -8.7% | · | -10.0% | -8.3% | -9.6% | · | -9.0% | |
| ROE | -11.8% | -11.3% | · | -9.6% | -11.6% | -10.9% | · | -13.3% | -11.2% | -9.4% | · | -11.0% | -9.1% | -10.5% | · | -9.8% |
Liquidität & Solvenz 2
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 13.2 | 16.3 | · | 14.6 | 16.1 | 12.0 | · | 13.2 | 15.1 | 21.3 | · | 12.3 | 18.5 | 13.0 | · | 15.0 | |
| Quick Ratio | 1.8 | 3.2 | · | 2.5 | 4.2 | 2.8 | · | 2.1 | 2.6 | 3.7 | · | 1.4 | 7.1 | 4.0 | · | 2.2 |
Bewertung (TTM) 8
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income TTM | $-146M | $-135M | · | $-134M | $-133M | $-122M | · | $-117M | $-105M | $-97M | · | $-97M | $-92M | $-92M | · | $-87M | |
| Market Cap | $1.12B | $1.31B | · | $1.17B | $875M | $397M | · | $723M | $478M | $927M | · | $330M | $423M | $257M | · | $127M | |
| P/E | -7.1 | -8.1 | · | -7.0 | -5.5 | -3.2 | · | -5.9 | -4.0 | -7.5 | · | -2.9 | -3.6 | -2.5 | · | -1.5 | |
| P/B | 2.9 | 3.2 | · | 2.9 | 2.7 | 1.8 | · | 2.6 | 1.6 | 2.8 | · | 1.3 | 1.6 | 1.3 | · | 0.6 | |
| P / Tangible Book | 2.9 | 3.2 | · | 2.9 | 2.7 | 1.8 | · | 2.6 | 1.6 | 2.8 | · | 1.3 | 1.6 | 1.3 | · | 0.6 | |
| P / Cash Flow | · | -40.4 | · | · | · | -12.2 | · | · | · | -30.7 | · | · | · | -12.5 | · | · | |
| P / FCF | · | -40.4 | · | · | · | -12.0 | · | · | · | -30.5 | · | · | · | -12.3 | · | · | |
| Earnings Yield | -14.0% | -12.3% | · | -14.2% | -18.0% | -31.0% | · | -17.1% | -24.9% | -13.4% | · | -34.7% | -28.0% | -39.6% | · | -68.8% |
Finanzberichte Gewinn- und Verlustrechnung, Bilanz, Cashflow — jährlich, letzte 5 Jahre
Gewinn- und Verlustrechnung
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Nettoergebnis | $-129M | $-128M | $-101M | $-89M | $-79M |
| Verwässerte EPS | $-1.47 | $-1.83 | $-1.96 | $-2.25 | $-2.07 |
Bilanz
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Liquiditätsgrad | 14.1 | 10.6 | 10.4 | 13.7 | 15.9 |
| Quick Ratio | 2.2 | 2.4 | 1.1 | 4.3 | 14.9 |
Cashflow
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Freier Cashflow | $-112M | $-114M | $-87M | $-77M | $-60M |
Meine Kennzahlen Ihre persönliche Watchlist — ausgewählte Zeilen aus den vollständigen Fundamentaldaten
Wählen Sie die Kennzahlen, die für Sie wichtig sind — klicken Sie auf das ➕ neben jeder Zeile in den vollständigen Fundamentaldaten oben.
Ihre Auswahl wird gespeichert und begleitet Sie über alle Ticker hinweg.
Institutionelle Eigentümer (13F) 192 Einreicher · $1.1B gesamt · Stand 30. Juni 2026
Institutionen, die diese Aktie in ihrer vierteljährlichen SEC-Formular 13F melden. Nur Long-Positionen; ein einzelner Einreicher kann für separate Optionsscheine zweimal erscheinen. Große gegenläufige Put/Call-Positionen spiegeln typischerweise Market-Making oder abgesicherte Bestände wider, nicht die gerichtete Überzeugung.
| Neue Positionen | Geschlossene Positionen | Erhöht | Abgenommen | Nettoveränderung der Aktien |
|---|---|---|---|---|
| 40 (-3 vs. Vorquartal) | 29 (+11 vs. Vorquartal) | 68 (+17 vs. Vorquartal) | 44 (-18 vs. Vorquartal) | +5.7M |
Verglichen mit Q1 2026. SEC-Formular 13F-Einreichungen sind innerhalb von 45 Tagen nach Quartalsende fällig, zuzüglich einer kurzen Pufferzeit für verspätete Einreicher — Quartale, die noch in diesem Fenster liegen, werden zugunsten des letzten vollständig berichteten Paares übersprungen.
| Institution | Wert | Aktien | % der verfolgten 13F | Typ |
|---|---|---|---|---|
| Nextech Invest Ltd. | $77.571.359 | 7.162.637 | 6,91% | Aktien |
| EcoR1 Capital, LLC | $72.865.496 | 6.728.116 | 6,49% | Aktien |
| VIKING GLOBAL INVESTORS LP | $55.522.832 | 5.126.762 | 4,95% | Aktien |
| STATE STREET CORP | $53.002.020 | 4.894.000 | 4,72% | Aktien |
| SR One Capital Management, LP | $49.984.609 | 4.615.384 | 4,45% | Aktien |
| Venrock Adviser, LLC | $46.783.055 | 4.319.765 | 4,17% | Aktien |
| NEA Management Company, LLC | $44.604.665 | 4.118.621 | 3,97% | Aktien |
| VANGUARD CAPITAL MANAGEMENT LLC | $42.791.160 | 3.951.169 | 3,81% | Aktien |
| Nextech Invest Ltd. | $42.655.712 | 5.285.714 | 3,80% | Aktien |
| AIHC Capital Management Ltd | $41.462.222 | 3.828.460 | 3,69% | Aktien |
| Column Group LLC | $38.346.615 | 3.540.777 | 3,42% | Aktien |
| ALKEON CAPITAL MANAGEMENT LLC | $33.845.158 | 3.125.130 | 3,01% | Aktien |
| VANGUARD GROUP INC | $32.441.356 | 3.965.936 | 2,89% | Aktien |
| CITADEL ADVISORS LLC | $23.789.416 | 2.196.622 | 2,12% | Aktien |
| First Turn Management, LLC | $21.847.186 | 2.017.284 | 1,95% | Aktien |
| ORBIMED ADVISORS LLC | $21.822.450 | 2.015.000 | 1,94% | Aktien |
| Integral Health Asset Management, LLC | $20.577.000 | 1.900.000 | 1,83% | Aktien |
| MPM BIOIMPACT LLC | $20.383.814 | 1.882.162 | 1,82% | Aktien |
| Vivo Capital, LLC | $20.022.352 | 1.848.786 | 1,78% | Aktien |
| GOLDMAN SACHS GROUP INC | $19.593.582 | 1.809.195 | 1,75% | Aktien |
| GEODE CAPITAL MANAGEMENT, LLC | $19.414.443 | 1.792.258 | 1,73% | Aktien |
| DIMENSIONAL FUND ADVISORS LP | $18.476.857 | 1.706.081 | 1,65% | Aktien |
| FMR LLC | $14.205.494 | 1.311.680 | 1,27% | Aktien |
| Woodline Partners LP | $13.510.587 | 1.247.515 | 1,20% | Aktien |
| ALGERT GLOBAL LLC | $13.161.623 | 1.215.293 | 1,17% | Aktien |
| BRAIDWELL LP | $13.153.468 | 1.214.540 | 1,17% | Aktien |
| Candriam S.C.A. | $12.764.594 | 1.179.768 | 1,14% | Aktien |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | $11.392.109 | 1.051.903 | 1,01% | Aktien |
| Defilade Capital Management, L.P. | $11.346.483 | 1.047.690 | 1,01% | Aktien |
| Siren, L.L.C. | $10.912.037 | 1.007.575 | 0,97% | Aktien |
| Euclidean Capital LLC | $10.715.310 | 989.410 | 0,95% | Aktien |
| ROYCE & ASSOCIATES LP | $10.609.761 | 979.664 | 0,94% | Aktien |
| EVENTIDE ASSET MANAGEMENT, LLC | $10.337.886 | 954.768 | 0,92% | Aktien |
| Qube Research & Technologies Ltd | $8.604.890 | 794.542 | 0,77% | Aktien |
| SPHERA FUNDS MANAGEMENT LTD. | $8.154.806 | 752.983 | 0,73% | Aktien |
| Jones Hill Capital LP | $8.093.400 | 747.313 | 0,72% | Aktien |
| SILVERARC CAPITAL MANAGEMENT, LLC | $8.001.995 | 738.873 | 0,71% | Aktien |
| NEXTBio Capital Management LP | $7.647.323 | 706.124 | 0,68% | Aktien |
| MILLENNIUM MANAGEMENT LLC | $7.556.026 | 697.694 | 0,67% | Aktien |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | $7.340.823 | 677.823 | 0,65% | Aktien |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $6.808.626 | 628.682 | 0,61% | Aktien |
| TWO SIGMA INVESTMENTS, LP | $6.537.681 | 603.664 | 0,58% | Aktien |
| ArrowMark Colorado Holdings LLC | $6.312.536 | 582.875 | 0,56% | Aktien |
| VANGUARD FIDUCIARY TRUST CO | $6.130.192 | 566.038 | 0,55% | Aktien |
| Connor, Clark & Lunn Investment Management Ltd. | $5.614.922 | 518.460 | 0,50% | Aktien |
| SUPERSTRING CAPITAL MANAGEMENT LP | $4.397.814 | 406.077 | 0,39% | Aktien |
| Blue Owl Capital Holdings LP | $4.332.000 | 400.000 | 0,39% | Aktien |
| VICTORY CAPITAL MANAGEMENT INC | $4.256.948 | 393.070 | 0,38% | Aktien |
| Redmile Group, LLC | $3.920.568 | 362.010 | 0,35% | Aktien |
| Boxer Capital Management, LLC | $3.790.500 | 350.000 | 0,34% | Aktien |
| BNP PARIBAS FINANCIAL MARKETS | $3.736.762 | 345.038 | 0,33% | Aktien |
| Squarepoint Ops LLC | $3.729.235 | 344.343 | 0,33% | Aktien |
| Pfizer Inc | $3.553.775 | 372.904 | 0,32% | Aktien |
| TD Asset Management Inc | $2.664.202 | 246.002 | 0,24% | Aktien |
| CITIGROUP INC | $2.647.339 | 244.445 | 0,24% | Aktien |
| BANK OF AMERICA CORP /DE/ | $2.638.892 | 243.665 | 0,24% | Aktien |
| Trexquant Investment LP | $2.402.300 | 221.819 | 0,21% | Aktien |
| XTX Topco Ltd | $2.359.066 | 217.827 | 0,21% | Aktien |
| UBS Group AG | $2.266.578 | 209.287 | 0,20% | Aktien |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $1.935.321 | 178.700 | 0,17% | Kaufoption |
| MANUFACTURERS LIFE INSURANCE COMPANY, THE | $1.886.824 | 174.222 | 0,17% | Aktien |
| AMERICAN CENTURY COMPANIES INC | $1.826.241 | 168.628 | 0,16% | Aktien |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $1.508.251 | 139.266 | 0,13% | Aktien |
| Jump Financial, LLC | $1.423.062 | 131.400 | 0,13% | Aktien |
| Atom Investors LP | $1.408.756 | 130.079 | 0,13% | Aktien |
| Ishara Investments LP | $1.332.090 | 123.000 | 0,12% | Aktien |
| Caption Management, LLC | $1.191.300 | 110.000 | 0,11% | Kaufoption |
| SPHERA FUNDS MANAGEMENT LTD. | $1.083.000 | 100.000 | 0,10% | Kaufoption |
| Caption Management, LLC | $1.083.000 | 100.000 | 0,10% | Verkaufsoption |
| RHUMBLINE ADVISERS | $1.017.131 | 93.919 | 0,09% | Aktien |
| Rafferty Asset Management, LLC | $982.963 | 90.763 | 0,09% | Aktien |
| Abu Dhabi Investment Council Co P.J.S.C | $968.646 | 89.441 | 0,09% | Aktien |
| Bank of New York Mellon Corp | $965.776 | 89.176 | 0,09% | Aktien |
| Swiss National Bank | $933.546 | 86.200 | 0,08% | Aktien |
| WINTON GROUP Ltd | $898.890 | 83.000 | 0,08% | Aktien |
| BlackRock, Inc. | $864.407 | 79.816 | 0,08% | Aktien |
| ALLIANCEBERNSTEIN L.P. | $808.473 | 63.810 | 0,07% | Aktien |
| WELLINGTON MANAGEMENT GROUP LLP | $745.169 | 68.806 | 0,07% | Aktien |
| WELLS FARGO & COMPANY/MN | $696.228 | 64.287 | 0,06% | Aktien |
| Engineers Gate Manager LP | $693.683 | 64.052 | 0,06% | Aktien |
| CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM | $612.835 | 48.369 | 0,05% | Aktien |
| Caption Management, LLC | $521.248 | 48.130 | 0,05% | Aktien |
| PROFUND ADVISORS LLC | $494.931 | 45.700 | 0,04% | Aktien |
| MetLife Investment Management, LLC | $474.787 | 43.840 | 0,04% | Aktien |
| TUDOR INVESTMENT CORP ET AL | $459.289 | 42.409 | 0,04% | Aktien |
| Virtus Investment Advisers, LLC | $428.489 | 39.565 | 0,04% | Aktien |
| Optimize Financial Inc | $409.596 | 32.328 | 0,04% | Aktien |
| AXQ CAPITAL, LP | $395.501 | 36.519 | 0,04% | Aktien |
| Quadrature Capital Ltd | $393.086 | 36.296 | 0,04% | Aktien |
| LMR Partners LLP | $381.942 | 35.267 | 0,03% | Aktien |
| MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. | $372.639 | 34.408 | 0,03% | Aktien |
| AlphaQuest LLC | $363.086 | 44.387 | 0,03% | Aktien |
| Russell Investments Group, Ltd. | $332.914 | 30.740 | 0,03% | Aktien |
| Brevan Howard Capital Management LP | $331.983 | 30.654 | 0,03% | Aktien |
| Invesco Ltd. | $318.456 | 29.405 | 0,03% | Aktien |
| Zurcher Kantonalbank (Zurich Cantonalbank) | $310.626 | 28.682 | 0,03% | Aktien |
| Vanguard Global Advisers, LLC | $306.457 | 28.297 | 0,03% | Aktien |
| D. E. Shaw & Co., Inc. | $287.103 | 26.510 | 0,03% | Aktien |
| CITADEL ADVISORS LLC | $281.580 | 26.000 | 0,03% | Kaufoption |
| VANGUARD ASSET MANAGEMENT, Ltd | $272.797 | 25.189 | 0,02% | Aktien |
Unternehmensinsider 11 Insider · 3 Führungskräfte · 9 Direktoren
| Insider | Rolle | Letzte Aktivität | Gehaltene Aktien | Käufe 12m | Verkäufe 12m | Netto 12m |
|---|---|---|---|---|---|---|
| Jacob Chacko | President and CEO | 2. Januar 2024 A | 808.544 | 0 | 0 | $0 |
| Dominic Piscitelli | Chief Financial Officer | 2. Januar 2024 A | 83.809 | 0 | 0 | $0 |
| Pratik S Multani | Chief Medical Officer | 2. Januar 2024 A | 23.809 | 0 | 0 | $0 |
| Richard A. Heyman | Direktor | 24. Juli 2026 M | 206.672 | 0 | 3 | $-161.062 |
| Angie You | Direktor | 14. Juni 2023 A | — | 0 | 0 | $0 |
| Mardi Dier | Direktor | 14. Juni 2023 A | — | 0 | 0 | $0 |
| Lori Anne Kunkel | Direktor | 14. Juni 2023 A | — | 0 | 0 | $0 |
| Steven L. Hoerter | Direktor | 14. Juni 2023 A | — | 0 | 0 | $0 |
| Peter Svennilson | Direktor | 16. Juni 2021 A | 4.768.181 | 0 | 0 | $0 |
| GORDON CARL L | Direktor | 16. Juni 2021 A | 2.212.571 | 0 | 0 | $0 |
| Richard H Scheller | Direktor | 24. Mai 2021 S | 39.092 | 0 | 0 | $0 |
Insider aus SEC-Einreichungen Form 3/4/5; Netto = nur P/S aus offenen Märkten
Aktivisten & 5%+-Eigentümer 2 Beteiligungen
Investoren mit SEC Schedule 13D — wirtschaftliches Eigentum über 5% mit der Absicht, Einfluss auf den Emittenten zu nehmen (aktivistische Beteiligungen, Board-Kampagnen, M&A). Jede Zeile zeigt den zuletzt bekannten Stand der Position dieses Melders.
| Anmelder | Eingereicht | Beteiligung | Status | Zweck | Einreichung |
|---|---|---|---|---|---|
| SR One Capital Management, LLC, SR One Capital Opportunities Fund I, LP, SR One Capital Opportunities Partners I, LP, AMZL, LP, SR One Capital SMA Partners, LP, SR One Capital Fund II Aggregator, LP, SR One Capital Partners II, LP, Simeon George ×2 Einreichungen | 14. August 2025 | 4,75% | Änderung | — | SEC |
| OrbiMed Advisors LLC, OrbiMed Capital GP VI LLC, OrbiMed Capital LLC ×5 Einreichungen | 27. Dezember 2022 | — | Erste Einreichung | — | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
ETF-Besitz Gehalten von 43 ETFs
Gewichtung spiegelt nur direkte Aktienbestände (N-PORT) wider; gehebelte oder derivatbasierte Fonds können zusätzliche Swap-Exposure halten, die hier nicht angezeigt wird.
| Fonds | Gewicht | Anteile | Stand | Quelle |
|---|---|---|---|---|
| BBC · ETFis Series Trust I | 0,78% | 29.424 NS | 30. April 2026 | N-PORT |
| CANC · Tema ETF Trust | 0,28% | 57.977 NS | 31. Mai 2026 | N-PORT |
| LABU · Direxion Shares ETF Trust | 0,24% | 124.292 NS | 30. April 2026 | N-PORT |
| ESSC · Strategy Shares | 0,08% | 2.136 NS | 30. April 2026 | N-PORT |
| AVSC · AMERICAN CENTURY ETF TRUST | 0,04% | 146.225 NS | 31. Mai 2026 | N-PORT |
| BIB · ProShares Trust | 0,04% | 3.711 NS | 31. Mai 2026 | N-PORT |
| DFAS · Dimensional ETF Trust | 0,02% | 327.184 NS | 30. April 2026 | N-PORT |
| RSSL · Global X Funds | 0,02% | 28.629 NS | 30. April 2026 | N-PORT |
| ITWO · ProShares Trust | 0,01% | 3.114 NS | 31. Mai 2026 | N-PORT |
| SCHA · SCHWAB STRATEGIC TRUST | 0,01% | 365.890 NS | 31. Mai 2026 | N-PORT |
| UWM · ProShares Trust | 0,01% | 2.435 NS | 31. Mai 2026 | N-PORT |
| FHLC · FIDELITY COVINGTON TRUST | 0,01% | 20.039 NS | 30. April 2026 | N-PORT |
| URTY · ProShares Trust | 0,01% | 2.463 NS | 31. Mai 2026 | N-PORT |
| DXUV · Dimensional ETF Trust | 0,01% | 2.102 NS | 30. April 2026 | N-PORT |
| DCOR · Dimensional ETF Trust | 0,00% | 9.920 NS | 30. April 2026 | N-PORT |
| ONEQ · Fidelity Commonwealth Trust | 0,00% | 40.897 NS | 31. Mai 2026 | N-PORT |
| MSSM · MORGAN STANLEY PATHWAY FUNDS | 0,00% | 2.346 NS | 31. Mai 2026 | N-PORT |
| DFAU · Dimensional ETF Trust | 0,00% | 30.514 NS | 30. April 2026 | N-PORT |
| HDG · ProShares Trust | 0,00% | 62 NS | 31. Mai 2026 | N-PORT |
| DFAC · Dimensional ETF Trust | 0,00% | 97.392 NS | 30. April 2026 | N-PORT |
| SCHB · SCHWAB STRATEGIC TRUST | 0,00% | 46.809 NS | 31. Mai 2026 | N-PORT |
| DFUS · Dimensional ETF Trust | 0,00% | 11.258 NS | 30. April 2026 | N-PORT |
| AVUS · AMERICAN CENTURY ETF TRUST | 0,00% | 7.147 NS | 31. Mai 2026 | N-PORT |
| VXF · VANGUARD INDEX FUNDS | — | — | 15. Juli 2026 | Täglich |
| VTI · VANGUARD INDEX FUNDS | — | — | 15. Juli 2026 | Täglich |
| VTWO · VANGUARD SCOTTSDALE FUNDS | — | — | 15. Juli 2026 | Täglich |
| VTWV · VANGUARD SCOTTSDALE FUNDS | — | — | 15. Juli 2026 | Täglich |
| VTWG · VANGUARD SCOTTSDALE FUNDS | — | — | 15. Juli 2026 | Täglich |
| VTHR · VANGUARD SCOTTSDALE FUNDS | — | — | 15. Juli 2026 | Täglich |
| ITOT · iShares Trust | — | — | 5. August 2026 | Täglich |
| IWV · iShares Trust | — | — | 18. August 2026 | Täglich |
| IWN · iShares Trust | — | — | 17. August 2026 | Täglich |
| IWO · iShares Trust | — | — | 18. August 2026 | Täglich |
| IWM · iShares Trust | — | — | 18. August 2026 | Täglich |
| IBB · iShares Trust | — | — | 18. August 2026 | Täglich |
| IWC · iShares Trust | — | — | 18. August 2026 | Täglich |
| PRFZ · Invesco Exchange-Traded Fund Trust | — | — | 13. Juli 2026 | Täglich |
| VHT · VANGUARD WORLD FUND | — | — | 20. Juli 2026 | Täglich |
| ISCB · iShares Trust | — | — | 5. August 2026 | Täglich |
| ISCG · iShares Trust | — | — | 5. August 2026 | Täglich |
| ISCV · iShares Trust | — | — | 5. August 2026 | Täglich |
| WSML · iShares Trust | — | — | 5. August 2026 | Täglich |
| IBBQ · Invesco Exchange-Traded Fund Trust … | — | — | 20. Juli 2026 | Täglich |